TFF Pharmaceuticals, Inc.
NASDAQ:TFFP
Overview | Financials
Company Name | TFF Pharmaceuticals, Inc. |
Symbol | TFFP |
Currency | USD |
Price | 1.63 |
Market Cap | 5,649,645 |
Dividend Yield | 0% |
52-week-range | 1.35 - 11 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Harlan F. Weisman |
Website | https://www.tffpharma.com |
An error occurred while fetching data.
About TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD